| pubmed-article:12164885 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12164885 | lifeskim:mentions | umls-concept:C0021246 | lld:lifeskim |
| pubmed-article:12164885 | lifeskim:mentions | umls-concept:C0022663 | lld:lifeskim |
| pubmed-article:12164885 | lifeskim:mentions | umls-concept:C0072973 | lld:lifeskim |
| pubmed-article:12164885 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12164885 | lifeskim:mentions | umls-concept:C0444956 | lld:lifeskim |
| pubmed-article:12164885 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12164885 | pubmed:dateCreated | 2002-8-7 | lld:pubmed |
| pubmed-article:12164885 | pubmed:abstractText | Despite the accumulating evidence of their efficacy, angiotensin-converting enzyme inhibitors (ACEi) still provide imperfect renoprotection. Up-titration above conventional doses and combined therapy with other antiproteinuric agents may serve to achieve renoprotection in patients at risk of rapid disease progression. | lld:pubmed |
| pubmed-article:12164885 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12164885 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12164885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12164885 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12164885 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12164885 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:RemuzziGiusep... | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:RuggenentiPie... | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:RemuzziAndrea... | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:SangalliFabio... | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:LepreMaria... | lld:pubmed |
| pubmed-article:12164885 | pubmed:author | pubmed-author:PisoniRoberto... | lld:pubmed |
| pubmed-article:12164885 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12164885 | pubmed:volume | 62 | lld:pubmed |
| pubmed-article:12164885 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12164885 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12164885 | pubmed:pagination | 1010-9 | lld:pubmed |
| pubmed-article:12164885 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:meshHeading | pubmed-meshheading:12164885... | lld:pubmed |
| pubmed-article:12164885 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12164885 | pubmed:articleTitle | Effect of high dose ramipril with or without indomethacin on glomerular selectivity. | lld:pubmed |
| pubmed-article:12164885 | pubmed:affiliation | Aldo & Cele Daccò Clinical Research Center for Rare Diseases, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy. | lld:pubmed |
| pubmed-article:12164885 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12164885 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12164885 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12164885 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12164885 | lld:pubmed |
